Natasha Slater n.slater1@keele.ac.uk
Polypharmacy in atrial fibrillation: A prospective analysis of mortality and ischemic stroke using the Clinical Practice Research Datalink
Slater, Natasha; White, Simon; Frisher, Martin
Authors
Simon White s.j.white@keele.ac.uk
Martin Frisher m.frisher@keele.ac.uk
Abstract
Background: Observational studies of polypharmacy and the risk of death or stroke in individuals with atrial fibrillation (AF) have produced inconsistent findings. By using propensity score matching (PSM) and Cox regression, this study aimed to determine whether polypharmacy (five to nine medicines) in the 3 months following AF diagnosis, is associated with an increased risk of death or ischemic stroke, compared to non‐polypharmacy (one to four medicines). Methods: A prospective cohort study using data from the Clinical Practice Research Datalink (2006–2019). Data from 23 629 individuals with AF were analyzed. Cox regression models were adjusted for age, gender, morbidities, obesity, alcohol, smoking, and wealth. In the PSM models, cases and controls with near identical health profiles were selected from the study pool. The risk of death and stroke were presented as hazard ratios (HRs) with 95% confidence intervals (CIs). Results: 68.9% (n = 16 271) of the participants had polypharmacy. PSM showed that polypharmacy was associated with an increased risk of death during follow‐up (HR 1.32; 95% CI: 1.19–1.47, p < .01), but not ischemic stroke (HR 0.84; 95% CI: 0.69–1.02, p = .08). Conclusion: Polypharmacy was associated with an increased risk of death during follow‐up, but not ischemic stroke, in individuals with AF. The effects of comorbidity and other confounding factors were reduced by using PSM. This study focused on the overall medication burden; however, further research is needed to identify which specific medications in polypharmacy regimens increase the risk of mortality in AF. These findings could inform prescribing practices in the future.
Citation
Slater, N., White, S., & Frisher, M. (2024). Polypharmacy in atrial fibrillation: A prospective analysis of mortality and ischemic stroke using the Clinical Practice Research Datalink. Journal of Arrhythmia, 40(1), 47-56. https://doi.org/10.1002/joa3.12961
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 7, 2023 |
Online Publication Date | Nov 27, 2023 |
Publication Date | 2024-02 |
Deposit Date | Dec 4, 2023 |
Journal | Journal of Arrhythmia |
Print ISSN | 1880-4276 |
Publisher | Wiley Open Access |
Peer Reviewed | Peer Reviewed |
Volume | 40 |
Issue | 1 |
Pages | 47-56 |
DOI | https://doi.org/10.1002/joa3.12961 |
Keywords | ischemic stroke, CPRD, atrial fibrillation, mortality, polypharmacy |
Public URL | https://keele-repository.worktribe.com/output/654977 |
Publisher URL | https://onlinelibrary.wiley.com/doi/10.1002/joa3.12961 |
You might also like
Peer assisted learning in pharmacy: The mentor and student perspective
(2018)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search